NCT06074965View on ClinicalTrials.gov

Impact of Two Medtronic Infusion Sets on Lipohypertrophy in Type 1 Diabetes (T1DM) Patients Thought to Have LH

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 5, 2022

Primary Completion Date

May 23, 2023

Study Completion Date

May 23, 2023

Conditions
DiabetesDiabetes Mellitus, Type 1Lipohypertrophy
Interventions
DEVICE

Medtronic Extended Infusion Set

Each subject will be given 2 types of infusion sets to wear and change sets per label use (3 days for Medtronic Quick-set™ and 7 days for Medtronic Extended).

Trial Locations (1)

00152

Azienda Ospedaliera San Camillo Forlanini, Roma

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Azienda Ospedaliera San Camillo Forlanini

OTHER